Full Text of HB0702 98th General Assembly
HB0702sam001 98TH GENERAL ASSEMBLY | Sen. Terry Link Filed: 5/3/2013
| | 09800HB0702sam001 | | LRB098 03526 JDS 44928 a |
|
| 1 | | AMENDMENT TO HOUSE BILL 702
| 2 | | AMENDMENT NO. ______. Amend House Bill 702 by replacing | 3 | | everything after the enacting clause with the following:
| 4 | | "Section 5. The Environmental Protection Act is amended by | 5 | | changing Section 3.360 as follows:
| 6 | | (415 ILCS 5/3.360) (was 415 ILCS 5/3.84)
| 7 | | Sec. 3.360. Potentially infectious medical waste.
| 8 | | (a) "Potentially infectious medical waste" means
the | 9 | | following types of waste generated in connection with the | 10 | | diagnosis,
treatment (i.e., provision of medical services), or | 11 | | immunization of
human beings or animals; research pertaining to | 12 | | the provision of medical
services; or the production or testing | 13 | | of biologicals:
| 14 | | (1) Cultures and stocks.
This waste shall include but | 15 | | not be limited to cultures and stocks of
agents infectious | 16 | | to humans, and associated biologicals; cultures from
|
| | | 09800HB0702sam001 | - 2 - | LRB098 03526 JDS 44928 a |
|
| 1 | | medical or pathological laboratories; cultures and stocks | 2 | | of infectious
agents from research and industrial | 3 | | laboratories; wastes from the
production of biologicals; | 4 | | discarded live or attenuated vaccines; or
culture dishes | 5 | | and devices used to transfer, inoculate, or mix cultures.
| 6 | | (2) Human pathological wastes. This waste shall | 7 | | include tissue, organs,
and body parts (except teeth and | 8 | | the contiguous
structures of bone and gum); body fluids | 9 | | that are removed during surgery,
autopsy, or other medical | 10 | | procedures; or specimens of body fluids and their
| 11 | | containers.
| 12 | | (3) Human blood and blood products. This waste shall | 13 | | include discarded
human blood, blood components (e.g., | 14 | | serum and plasma), or saturated material
containing free | 15 | | flowing blood or blood components.
| 16 | | (4) Used sharps. This waste shall include but not be | 17 | | limited to
discarded sharps used in animal or human patient | 18 | | care, medical
research, or clinical or pharmaceutical | 19 | | laboratories; hypodermic,
intravenous, or other medical
| 20 | | needles; hypodermic or intravenous syringes; Pasteur | 21 | | pipettes; scalpel
blades; or blood vials. This waste shall | 22 | | also include but not be limited
to other types of broken or | 23 | | unbroken glass (including slides and cover
slips) in | 24 | | contact with infectious agents.
| 25 | | (5) Animal waste. Animal waste means discarded | 26 | | materials, including
carcasses, body parts, body fluids, |
| | | 09800HB0702sam001 | - 3 - | LRB098 03526 JDS 44928 a |
|
| 1 | | blood, or bedding originating from animals
inoculated | 2 | | during research, production of biologicals, or | 3 | | pharmaceutical
testing with agents infectious to humans.
| 4 | | (6) Isolation waste. This waste shall include | 5 | | discarded materials
contaminated with blood, excretions, | 6 | | exudates, and secretions from humans
that are isolated to | 7 | | protect others from highly communicable diseases.
"Highly | 8 | | communicable diseases" means those diseases identified by | 9 | | the Board
in rules adopted under subsection (e) of Section | 10 | | 56.2 of this Act.
| 11 | | (7) Unused sharps. This waste shall include but not be | 12 | | limited to the
following unused, discarded sharps: | 13 | | hypodermic, intravenous, or
other needles; hypodermic or | 14 | | intravenous syringes; or scalpel blades.
| 15 | | (b) Potentially infectious medical waste does not include:
| 16 | | (1) waste generated as general household waste;
| 17 | | (2) waste (except for sharps) for which the infectious | 18 | | potential has
been eliminated by treatment; or
| 19 | | (3) sharps that meet both of the following conditions:
| 20 | | (A) the infectious potential has been eliminated | 21 | | from the sharps by
treatment; and
| 22 | | (B) the sharps are rendered unrecognizable by | 23 | | treatment ; or .
| 24 | | (4) sharps that are managed in accordance with the | 25 | | following requirements: | 26 | | (A) the infectious potential is eliminated from |
| | | 09800HB0702sam001 | - 4 - | LRB098 03526 JDS 44928 a |
|
| 1 | | the sharps by treatment at a facility that is permitted | 2 | | by the Agency for the treatment of potentially | 3 | | infectious medical waste; | 4 | | (B) the sharps are certified by the treatment | 5 | | facility as non-special waste in accordance with | 6 | | Section 22.48 of this Act; | 7 | | (C) the sharps are packaged at the treatment | 8 | | facility the same as required under Board rules for | 9 | | potentially infectious medical waste; | 10 | | (D) the sharps are transported under the custody of | 11 | | the treatment facility to a landfill permitted by the | 12 | | Agency under Section 21 of this Act to accept municipal | 13 | | waste for disposal; and | 14 | | (E) the activities in subparagraphs (A) through | 15 | | (D) of this paragraph (4) are authorized in, and | 16 | | conducted in accordance with, a permit issued by the | 17 | | Agency to the treatment facility. | 18 | | (Source: P.A. 92-574, eff. 6-26-02.)".
|
|